All Industry News articles – Page 4
-
NewsReichman University announces new Scojen Institute for Synthetic Biology
A new research institute for the development of cutting-edge technologies in the field of synthetic biology is to be set up, acting as a hub for interdisciplinary research.
-
NewsUK launches 10-year science strategy to save lives and boost prosperity
The UK Health Security Agency (UKHSA) has launched a ten-year Science Strategy, setting out how UKHSA’s science can save more lives, secure health and prosperity and contribute to the UK’s ambition to be a global science superpower.
-
NewsWarning over lack of ‘substantial evidence’ for FDA approved antibiotic
Drugs approved in the US require “substantial evidence” that they are effective, but an investigation by The BMJ into the recent approval of the antibiotic Recarbrio from Merck suggests that these standards are being bypassed.
-
NewsAntibiotics should be halted upon incision closure
New guidelines: antibiotics administered before and during surgery should be discontinued immediately after a patient’s incision is closed, according to updated recommendations for preventing surgical site infections.
-
NewsMonoclonal antibody programme targets mucormycosis
Vitalex Biosciences has been awarded an SBIR Phase 2 grant from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health for VX-01, a monoclonal antibody (mAB) programme targeting the debilitating indication of the fungal disease, mucormycosis.
-
NewsEuropean-funded €2.3m project will revolutionize bioprinting of living materials
The PRISM-LT project has received a €2.3 million grant for a five-year program that aims to create an adaptable platform for 3D bioprinting of living tissue with dynamic functionalities and predictable shapes.
-
NewsDr Rob Turner appointed as General Manager of Wickham Micro
Wickham Micro, a leading UK provider of microbiology testing services, has announced the appointment of Dr. Rob Turner as the new General Manager, as part of the company’s ongoing investment strategy to drive growth and innovation.
-
NewsWHO warns of dearth of new antibiotics, especially those targeting drug-resistant pathogens
A review from WHO on the number of new antibiotics currently in the pipeline shows that just 12 new antibiotics have entered the market in the five years from 2017-21.
-
NewsIntellifoods Labs, LLC teams with Mason scientists to cut food bacterial contamination detection time
Mason Associate Professor of Infectious Diseases and Microbiology, Ramin M Hakami has received $35,000 in grants from Intellifoods Labs, LLC to continue examining methods to reduce the time to detect the presence of bacteria in food samples.
-
![PET depolymerization reactor - CrÇdit photo Carbios[2][15]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/6/5/8/1658_petdepolymerizationreactorcrcditphotocarbios215_545583.jpg)
NewsFashion company joins fibre-to-fibre consortium founded by Carbios, On, Patagonia, PUMA and Salomon
Carbios, a pioneer of biological technologies for reinventing the life cycle of plastics and textiles, has signed an agreement with fashion company PVH Corp to join its fibre-to-fibre consortium founded with On, Patagonia, PUMA, and Salomon1.
-
NewsThree new appointments announced at AOAC International
Dr Katerina Mastovska has been named Deputy Executive Director and Chief Science Officer with AOAC International.
-
NewsBiomedical institutions agree on a set of open science practices to monitor
Eighty stakeholders from twenty major biomedical research institutions across the globe have agreed upon a list of 19 open science practices to be implemented and monitored.
-
NewsThe wait is over - AMI launches its new Jobs Board!
Applied Microbiology International is excited to announce the launch of its new Jobs Board.
-
NewsScientists create computer simulation based on digital microbes
Researchers at University of Galway associated with APC Microbiome Ireland, a world-leading SFI Research Centre, have created a resource of over 7,000 digital microbes – enabling computer simulations of how drug treatments work and how patients may respond. The resource is a milestone in scientific understanding of human response to ...
-
News Vésale Bioscience receives €1.8M grant from European Innovation Council for PhageDiag project
Vésale Bioscience has announced it has received €1.8M in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project, a phagogram using artificial intelligence that enables decentralized diagnostics and personalized treatment.
-
NewsGeneral Biomics and The Jackson Laboratory announce intellectual property licensing agreement
General Biomics, Inc. and The Jackson Laboratory (JAX) have announced an expansive and exclusive intellectual property licensing agreement across six areas of human health.
-
NewsUS approves world’s first vaccine to protect honey bees
The world’s first vaccine for honey bees has been approved by authorities in the US.
-
NewsGamechanging project could propel anti-microbial peptides into forefront of AMR battle
Experts from the University of Huddersfield have teamed up with an international consortium of partners for a four-year research project that aims to develop a new method for the commercial production of anti-microbial peptides (AMPs).
-
NewsApplied Microbiology International announces plans for new open access journal, Sustainable Microbiology
Applied Microbiology International has announced that it will soon be launching a new open access journal, Sustainable Microbiology. It will be the first new journal launched by the society since Microbial Biotechnology in 2008 and will be published in partnership with Oxford University Press. Sustainable Microbiology is ...
-
NewsApplied Microbiology International launches new corporate membership programme packed with benefits
Applied Microbiology International (AMI) is delighted to launch its corporate membership programme, with a packed list of benefits and opportunities to fit the needs of any organisation.
